Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
More info
16 Apr 2021
Press Release April 16th 2021
Read more
09 Apr 2021
Menarini Pills of Art Junior project launched, video clips made by the younger generations for children and teenagers
Watchword: getting the younger generations talking about art. Following on from the success of the Menarini Pills of Art, with 18 million views worldwide, Menarini now launches the ‘junior’ version, in which young art expert...
Read more
08 Apr 2021
Press Release 8th april 2021
Read more
02 Apr 2021
Menarini Group and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize ELZONRIS® (Tagraxofusp) in Japan
FLORENCE, ITALY March 29 th , 2021 – The Menarini Group announced today that it has entered into an exclusive license agreement for the development and commercialization of ELZONRIS® (tagraxofusp) in the territory of Japan w...
Read more
08 Mar 2021
Press Release March 5th
Read more
22 Jan 2021
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Awareness Day
23 rd January 2021 marks the second annual BPDCN Awareness Day (#BPDCNday) since it received its own classification as a distinct hematologic malignancy by the World Health Organization (WHO).
Read more
Page 1 of 6First   Previous   [1]  2  3  4  5  6  Next   Last